SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4ozy'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1FKP_A_NVPA999_1 (HIV-1 RT, A-CHAIN)	4ozy	POLY(BETA-D-MANNURON ATE) C5 EPIMERASE (Pseudomonas syringae group genomosp. 3)	5 / 11	LEU A 467 ASN A 430 VAL A 404 GLY A 411 LEU A 475	None	1.41A	1fkpA-4ozyA: undetectable	1fkpA-4ozyA: 22.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ME7_A_MOAA600_1 (INOSINE-5'-MONOPHOSP HATE DEHYDROGENASE)	4ozy	POLY(BETA-D-MANNURON ATE) C5 EPIMERASE (Pseudomonas syringae group genomosp. 3)	4 / 8	ASP A 331 SER A 357 ILE A 381 GLY A 334	MLY A 356 ( 3.5A) MLY A 356 ( 4.6A) None None	0.78A	1me7A-4ozyA: undetectable	1me7A-4ozyA: 23.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1MEI_A_MOAA600_1 (INOSINE-5'-MONOPHOSP HATE DEHYDROGENASE)	4ozy	POLY(BETA-D-MANNURON ATE) C5 EPIMERASE (Pseudomonas syringae group genomosp. 3)	4 / 8	ASP A 331 SER A 357 ILE A 381 GLY A 334	MLY A 356 ( 3.5A) MLY A 356 ( 4.6A) None None	0.80A	1meiA-4ozyA: undetectable	1meiA-4ozyA: 23.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1MOG_A_RBFA200_1 (DODECIN)	4ozy	POLY(BETA-D-MANNURON ATE) C5 EPIMERASE (Pseudomonas syringae group genomosp. 3)	3 / 3	PHE A 194 TRP A 122 GLU A 121	None	1.17A	1mogA-4ozyA: undetectable	1mogA-4ozyA: 10.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ONI_I_BEZI518_0 (14.5 KDA TRANSLATIONAL INHIBITOR PROTEIN)	4ozy	POLY(BETA-D-MANNURON ATE) C5 EPIMERASE (Pseudomonas syringae group genomosp. 3)	4 / 7	ILE A 381 GLY A 364 ASN A 359 ASN A 360	None	0.98A	1oniG-4ozyA: undetectable 1oniI-4ozyA: undetectable	1oniG-4ozyA: 15.60 1oniI-4ozyA: 15.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1Q23_A_FUAA702_1 (CHLORAMPHENICOL ACETYLTRANSFERASE)	4ozy	POLY(BETA-D-MANNURON ATE) C5 EPIMERASE (Pseudomonas syringae group genomosp. 3)	5 / 12	PHE A 227 LEU A 185 VAL A 208 ALA A 219 ALA A 210	None	1.07A	1q23A-4ozyA: undetectable 1q23B-4ozyA: undetectable	1q23A-4ozyA: 21.61 1q23B-4ozyA: 21.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QHY_A_CLMA888_0 (CHLORAMPHENICOL PHOSPHOTRANSFERASE)	4ozy	POLY(BETA-D-MANNURON ATE) C5 EPIMERASE (Pseudomonas syringae group genomosp. 3)	4 / 6	MET A 134 ALA A 101 GLU A 105 GLU A 106	None	1.44A	1qhyA-4ozyA: undetectable	1qhyA-4ozyA: 16.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1SH9_B_RITB301_2 (POL POLYPROTEIN)	4ozy	POLY(BETA-D-MANNURON ATE) C5 EPIMERASE (Pseudomonas syringae group genomosp. 3)	5 / 10	ASP A 368 ILE A 343 ILE A 342 GLY A 364 ILE A 381	None	1.07A	1sh9B-4ozyA: undetectable	1sh9B-4ozyA: 14.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2H42_C_VIAC903_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE)	4ozy	POLY(BETA-D-MANNURON ATE) C5 EPIMERASE (Pseudomonas syringae group genomosp. 3)	5 / 12	LEU A 399 ILE A 343 ALA A 328 LEU A 75 ILE A 326	None	1.00A	2h42C-4ozyA: undetectable	2h42C-4ozyA: 19.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2OUZ_A_C3DA999_1 (ESTROGEN RECEPTOR)	4ozy	POLY(BETA-D-MANNURON ATE) C5 EPIMERASE (Pseudomonas syringae group genomosp. 3)	4 / 6	ASP A 225 GLU A 226 TRP A 290 ARG A 215	None	0.81A	2ouzA-4ozyA: undetectable	2ouzA-4ozyA: 19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2QHF_A_ACTA508_0 (CHORISMATE SYNTHASE)	4ozy	POLY(BETA-D-MANNURON ATE) C5 EPIMERASE (Pseudomonas syringae group genomosp. 3)	4 / 5	ARG A 447 ASP A 441 ALA A 456 ILE A 449	None	1.15A	2qhfA-4ozyA: undetectable	2qhfA-4ozyA: 21.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2QQT_A_AINA596_1 (LACTOPEROXIDASE)	4ozy	POLY(BETA-D-MANNURON ATE) C5 EPIMERASE (Pseudomonas syringae group genomosp. 3)	4 / 6	ARG A 186 GLU A 213 GLN A 189 PRO A 229	None MLY A 191 ( 4.8A) None None	1.26A	2qqtA-4ozyA: undetectable	2qqtA-4ozyA: 21.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2R5P_B_MK1B902_1 (PROTEASE)	4ozy	POLY(BETA-D-MANNURON ATE) C5 EPIMERASE (Pseudomonas syringae group genomosp. 3)	5 / 12	VAL A 303 ILE A 316 GLY A 315 GLY A 292 ILE A 281	None	1.03A	2r5pA-4ozyA: undetectable	2r5pA-4ozyA: 13.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2R5P_D_MK1D902_1 (PROTEASE)	4ozy	POLY(BETA-D-MANNURON ATE) C5 EPIMERASE (Pseudomonas syringae group genomosp. 3)	5 / 12	VAL A 303 ILE A 316 GLY A 315 GLY A 292 ILE A 281	None	1.03A	2r5pC-4ozyA: undetectable	2r5pC-4ozyA: 13.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2XDC_C_DVAC8_0 (GRAMICIDIN A)	4ozy	POLY(BETA-D-MANNURON ATE) C5 EPIMERASE (Pseudomonas syringae group genomosp. 3)	3 / 3	VAL A 303 TRP A 240 TRP A 280	None	1.07A	2xdcC-4ozyA: undetectable 2xdcD-4ozyA: undetectable	2xdcC-4ozyA: 5.67 2xdcD-4ozyA: 5.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ZXW_W_CHDW1060_0 (CYTOCHROME C OXIDASE POLYPEPTIDE 7A1 CYTOCHROME C OXIDASE SUBUNIT 1)	4ozy	POLY(BETA-D-MANNURON ATE) C5 EPIMERASE (Pseudomonas syringae group genomosp. 3)	4 / 7	ILE A 477 LEU A 475 ARG A 415 THR A 390	None	1.21A	2zxwN-4ozyA: undetectable 2zxwW-4ozyA: undetectable	2zxwN-4ozyA: 20.85 2zxwW-4ozyA: 10.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ZZN_A_SAMA401_0 (UNCHARACTERIZED PROTEIN MJ0883)	4ozy	POLY(BETA-D-MANNURON ATE) C5 EPIMERASE (Pseudomonas syringae group genomosp. 3)	5 / 12	TYR A 291 PHE A 293 GLY A 315 VAL A 303 PHE A 301	None	1.14A	2zznA-4ozyA: undetectable	2zznA-4ozyA: 22.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3A8I_A_C2FA401_0 (AMINOMETHYLTRANSFERA SE)	4ozy	POLY(BETA-D-MANNURON ATE) C5 EPIMERASE (Pseudomonas syringae group genomosp. 3)	5 / 12	MET A 249 ILE A 195 VAL A 231 MET A 246 PHE A 176	None	1.43A	3a8iA-4ozyA: undetectable	3a8iA-4ozyA: 21.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3GCL_A_AINA609_1 (LACTOPEROXIDASE)	4ozy	POLY(BETA-D-MANNURON ATE) C5 EPIMERASE (Pseudomonas syringae group genomosp. 3)	4 / 6	ARG A 186 GLU A 213 GLN A 189 PRO A 229	None MLY A 191 ( 4.8A) None None	1.23A	3gclA-4ozyA: undetectable	3gclA-4ozyA: 21.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JAY_A_SAMA1102_1 (STRUCTURAL PROTEIN VP3)	4ozy	POLY(BETA-D-MANNURON ATE) C5 EPIMERASE (Pseudomonas syringae group genomosp. 3)	3 / 3	ARG A 369 ASP A 317 ASP A 368	None	0.81A	3jayA-4ozyA: undetectable	3jayA-4ozyA: 17.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JB2_A_SAMA1102_1 (STRUCTURAL PROTEIN VP3)	4ozy	POLY(BETA-D-MANNURON ATE) C5 EPIMERASE (Pseudomonas syringae group genomosp. 3)	3 / 3	ARG A 369 ASP A 317 ASP A 368	None	0.72A	3jb2A-4ozyA: undetectable	3jb2A-4ozyA: 17.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JB3_A_SAMA1102_1 (STRUCTURAL PROTEIN VP3)	4ozy	POLY(BETA-D-MANNURON ATE) C5 EPIMERASE (Pseudomonas syringae group genomosp. 3)	3 / 3	ARG A 369 ASP A 317 ASP A 368	None	0.71A	3jb3A-4ozyA: undetectable	3jb3A-4ozyA: 17.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3LP1_A_NVPA701_1 (REVERSE TRANSCRIPTASE/RIBONU CLEASE H)	4ozy	POLY(BETA-D-MANNURON ATE) C5 EPIMERASE (Pseudomonas syringae group genomosp. 3)	5 / 10	LEU A 467 ASN A 430 VAL A 404 GLY A 411 LEU A 475	None	1.39A	3lp1A-4ozyA: undetectable	3lp1A-4ozyA: 21.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MS9_B_STIB1_2 (TYROSINE-PROTEIN KINASE ABL1)	4ozy	POLY(BETA-D-MANNURON ATE) C5 EPIMERASE (Pseudomonas syringae group genomosp. 3)	4 / 7	TYR A 294 VAL A 376 VAL A 347 ILE A 327	None	1.18A	3ms9B-4ozyA: undetectable	3ms9B-4ozyA: 20.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NRR_B_D16B520_1 (DIHYDROFOLATE REDUCTASE-THYMIDYLAT E SYNTHASE)	4ozy	POLY(BETA-D-MANNURON ATE) C5 EPIMERASE (Pseudomonas syringae group genomosp. 3)	5 / 12	HIS A 339 LEU A 391 ARG A 413 ILE A 381 LEU A 399	None	1.02A	3nrrB-4ozyA: undetectable	3nrrB-4ozyA: 23.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NY4_A_SMXA309_1 (BETA-LACTAMASE)	4ozy	POLY(BETA-D-MANNURON ATE) C5 EPIMERASE (Pseudomonas syringae group genomosp. 3)	4 / 5	ILE A 342 ARG A 413 THR A 390 GLU A 393	None	1.46A	3ny4A-4ozyA: undetectable	3ny4A-4ozyA: 20.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SXJ_A_SAMA258_0 (PUTATIVE METHYLTRANSFERASE)	4ozy	POLY(BETA-D-MANNURON ATE) C5 EPIMERASE (Pseudomonas syringae group genomosp. 3)	5 / 12	GLY A 411 GLY A 388 LEU A 432 ALA A 427 ASN A 470	None	1.29A	3sxjA-4ozyA: undetectable	3sxjA-4ozyA: 19.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SXJ_B_SAMB258_0 (PUTATIVE METHYLTRANSFERASE)	4ozy	POLY(BETA-D-MANNURON ATE) C5 EPIMERASE (Pseudomonas syringae group genomosp. 3)	5 / 12	GLY A 411 GLY A 388 LEU A 432 ALA A 427 ASN A 470	None	1.29A	3sxjB-4ozyA: undetectable	3sxjB-4ozyA: 19.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ZQ8_A_DVAA8_0 (VAL-GRAMICIDIN A)	4ozy	POLY(BETA-D-MANNURON ATE) C5 EPIMERASE (Pseudomonas syringae group genomosp. 3)	3 / 3	VAL A 303 TRP A 240 TRP A 280	None	1.11A	3zq8A-4ozyA: undetectable 3zq8B-4ozyA: undetectable	3zq8A-4ozyA: 5.67 3zq8B-4ozyA: 5.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EJJ_C_NCTC501_1 (CYTOCHROME P450 2A6)	4ozy	POLY(BETA-D-MANNURON ATE) C5 EPIMERASE (Pseudomonas syringae group genomosp. 3)	4 / 5	PHE A 293 PHE A 301 ILE A 281 THR A 239	None	0.88A	4ejjC-4ozyA: undetectable	4ejjC-4ozyA: 23.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FGL_C_CLQC303_0 (RIBOSYLDIHYDRONICOTI NAMIDE DEHYDROGENASE [QUINONE])	4ozy	POLY(BETA-D-MANNURON ATE) C5 EPIMERASE (Pseudomonas syringae group genomosp. 3)	4 / 5	GLY A 114 GLY A 115 ASN A 117 GLU A 111	None	1.06A	4fglC-4ozyA: undetectable	4fglC-4ozyA: 17.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4M2X_A_TMQA202_2 (DIHYDROFOLATE REDUCTASE)	4ozy	POLY(BETA-D-MANNURON ATE) C5 EPIMERASE (Pseudomonas syringae group genomosp. 3)	3 / 3	TRP A 234 GLN A 238 THR A 233	None	0.83A	4m2xA-4ozyA: undetectable	4m2xA-4ozyA: 15.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Q0B_A_NVPA901_1 (HIV-1 REVERSE TRANSCRIPTASE, P66 SUBUNIT)	4ozy	POLY(BETA-D-MANNURON ATE) C5 EPIMERASE (Pseudomonas syringae group genomosp. 3)	4 / 8	LEU A 399 VAL A 414 VAL A 435 LEU A 367	None	1.18A	4q0bA-4ozyA: undetectable	4q0bA-4ozyA: 22.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Y0P_A_TE4A201_1 (BETA-LACTOGLOBULIN)	4ozy	POLY(BETA-D-MANNURON ATE) C5 EPIMERASE (Pseudomonas syringae group genomosp. 3)	5 / 12	VAL A 231 LEU A 145 ILE A 168 ILE A 178 MET A 201	None	1.16A	4y0pA-4ozyA: undetectable	4y0pA-4ozyA: 17.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ENT_C_MIYC901_1 (MULTIDRUG EFFLUX PUMP SUBUNIT ACRB,MULTIDRUG EFFLUX PUMP SUBUNIT ACRB)	4ozy	POLY(BETA-D-MANNURON ATE) C5 EPIMERASE (Pseudomonas syringae group genomosp. 3)	5 / 9	SER A 394 GLY A 388 SER A 363 ILE A 412 ALA A 427	None	1.38A	5entC-4ozyA: undetectable	5entC-4ozyA: 21.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5KR2_A_ROCA101_1 (PROTEASE PR5-SQV)	4ozy	POLY(BETA-D-MANNURON ATE) C5 EPIMERASE (Pseudomonas syringae group genomosp. 3)	5 / 9	ALA A 287 ASP A 288 ILE A 312 GLY A 292 ILE A 316	None	1.31A	5kr2A-4ozyA: undetectable	5kr2A-4ozyA: 14.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5M35_B_BEZB302_0 (14-3-3 PROTEIN ZETA/DELTA)	4ozy	POLY(BETA-D-MANNURON ATE) C5 EPIMERASE (Pseudomonas syringae group genomosp. 3)	3 / 3	MET A 103 GLN A 131 ARG A 102	None	1.14A	5m35B-4ozyA: undetectable	5m35B-4ozyA: 20.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5M36_A_BEZA303_0 (14-3-3 PROTEIN ZETA/DELTA)	4ozy	POLY(BETA-D-MANNURON ATE) C5 EPIMERASE (Pseudomonas syringae group genomosp. 3)	3 / 3	MET A 103 GLN A 131 ARG A 102	None	1.08A	5m36A-4ozyA: undetectable	5m36A-4ozyA: 20.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VOO_D_C2FD3001_0 (5-METHYLTETRAHYDROFO LATE HOMOCYSTEINE S-METHYLTRANSFERASE)	4ozy	POLY(BETA-D-MANNURON ATE) C5 EPIMERASE (Pseudomonas syringae group genomosp. 3)	5 / 12	ASN A 306 GLY A 305 MET A 246 VAL A 231 ILE A 241	None	1.15A	5vooD-4ozyA: undetectable	5vooD-4ozyA: 19.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BEC_C_RBTC601_1 (SCAFFOLD PROTEIN D13)	4ozy	POLY(BETA-D-MANNURON ATE) C5 EPIMERASE (Pseudomonas syringae group genomosp. 3)	5 / 12	VAL A 259 PRO A 76 PHE A 353 PRO A 318 ILE A 352	None	1.43A	6becA-4ozyA: undetectable 6becB-4ozyA: undetectable 6becC-4ozyA: undetectable	6becA-4ozyA: 21.94 6becB-4ozyA: 21.94 6becC-4ozyA: 21.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6FN9_A_BEZA302_0 (14-3-3 PROTEIN ZETA/DELTA)	4ozy	POLY(BETA-D-MANNURON ATE) C5 EPIMERASE (Pseudomonas syringae group genomosp. 3)	3 / 3	MET A 103 GLN A 131 ARG A 102	None	1.12A	6fn9A-4ozyA: undetectable	6fn9A-4ozyA: 20.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6FNA_B_BEZB302_0 (14-3-3 PROTEIN ZETA/DELTA)	4ozy	POLY(BETA-D-MANNURON ATE) C5 EPIMERASE (Pseudomonas syringae group genomosp. 3)	3 / 3	MET A 103 GLN A 131 ARG A 102	None	1.15A	6fnaB-4ozyA: undetectable	6fnaB-4ozyA: 20.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6FNB_A_BEZA301_0 (14-3-3 PROTEIN ZETA/DELTA)	4ozy	POLY(BETA-D-MANNURON ATE) C5 EPIMERASE (Pseudomonas syringae group genomosp. 3)	3 / 3	MET A 103 GLN A 131 ARG A 102	None	1.10A	6fnbA-4ozyA: undetectable	6fnbA-4ozyA: 20.66

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1FKP_A_NVPA999_1","HIV-1 RT, A-CHAIN","4ozy","POLY(BETA-D-MANNURONATE) C5 EPIMERASE","Pseudomonas syringae group genomosp. 3",5,"LEU A 467;ASN A 430;VAL A 404;GLY A 411;LEU A 475","None","1.41A","1fkpA-4ozyA:undetectable","1fkpA-4ozyA:22.50"],["1ME7_A_MOAA600_1","INOSINE-5'-MONOPHOSPHATE DEHYDROGENASE","4ozy","POLY(BETA-D-MANNURONATE) C5 EPIMERASE","Pseudomonas syringae group genomosp. 3",4,"ASP A 331;SER A 357;ILE A 381;GLY A 334","MLY A 356 ( 3.5A);MLY A 356 ( 4.6A);None;None","0.78A","1me7A-4ozyA:undetectable","1me7A-4ozyA:23.26"],["1MEI_A_MOAA600_1","INOSINE-5'-MONOPHOSPHATE DEHYDROGENASE","4ozy","POLY(BETA-D-MANNURONATE) C5 EPIMERASE","Pseudomonas syringae group genomosp. 3",4,"ASP A 331;SER A 357;ILE A 381;GLY A 334","MLY A 356 ( 3.5A);MLY A 356 ( 4.6A);None;None","0.80A","1meiA-4ozyA:undetectable","1meiA-4ozyA:23.26"],["1MOG_A_RBFA200_1","DODECIN","4ozy","POLY(BETA-D-MANNURONATE) C5 EPIMERASE","Pseudomonas syringae group genomosp. 3",3,"PHE A 194;TRP A 122;GLU A 121","None","1.17A","1mogA-4ozyA:undetectable","1mogA-4ozyA:10.00"],["1ONI_I_BEZI518_0","14.5 KDA TRANSLATIONAL INHIBITOR PROTEIN","4ozy","POLY(BETA-D-MANNURONATE) C5 EPIMERASE","Pseudomonas syringae group genomosp. 3",4,"ILE A 381;GLY A 364;ASN A 359;ASN A 360","None","0.98A","1oniG-4ozyA:undetectable;1oniI-4ozyA:undetectable","1oniG-4ozyA:15.60;1oniI-4ozyA:15.60"],["1Q23_A_FUAA702_1","CHLORAMPHENICOL ACETYLTRANSFERASE;CHLORAMPHENICOL ACETYLTRANSFERASE","4ozy","POLY(BETA-D-MANNURONATE) C5 EPIMERASE","Pseudomonas syringae group genomosp. 3",5,"PHE A 227;LEU A 185;VAL A 208;ALA A 219;ALA A 210","None","1.07A","1q23A-4ozyA:undetectable;1q23B-4ozyA:undetectable","1q23A-4ozyA:21.61;1q23B-4ozyA:21.61"],["1QHY_A_CLMA888_0","CHLORAMPHENICOL PHOSPHOTRANSFERASE","4ozy","POLY(BETA-D-MANNURONATE) C5 EPIMERASE","Pseudomonas syringae group genomosp. 3",4,"MET A 134;ALA A 101;GLU A 105;GLU A 106","None","1.44A","1qhyA-4ozyA:undetectable","1qhyA-4ozyA:16.63"],["1SH9_B_RITB301_2","POL POLYPROTEIN","4ozy","POLY(BETA-D-MANNURONATE) C5 EPIMERASE","Pseudomonas syringae group genomosp. 3",5,"ASP A 368;ILE A 343;ILE A 342;GLY A 364;ILE A 381","None","1.07A","1sh9B-4ozyA:undetectable","1sh9B-4ozyA:14.92"],["2H42_C_VIAC903_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE","4ozy","POLY(BETA-D-MANNURONATE) C5 EPIMERASE","Pseudomonas syringae group genomosp. 3",5,"LEU A 399;ILE A 343;ALA A 328;LEU A  75;ILE A 326","None","1.00A","2h42C-4ozyA:undetectable","2h42C-4ozyA:19.48"],["2OUZ_A_C3DA999_1","ESTROGEN RECEPTOR","4ozy","POLY(BETA-D-MANNURONATE) C5 EPIMERASE","Pseudomonas syringae group genomosp. 3",4,"ASP A 225;GLU A 226;TRP A 290;ARG A 215","None","0.81A","2ouzA-4ozyA:undetectable","2ouzA-4ozyA:19.54"],["2QHF_A_ACTA508_0","CHORISMATE SYNTHASE","4ozy","POLY(BETA-D-MANNURONATE) C5 EPIMERASE","Pseudomonas syringae group genomosp. 3",4,"ARG A 447;ASP A 441;ALA A 456;ILE A 449","None","1.15A","2qhfA-4ozyA:undetectable","2qhfA-4ozyA:21.40"],["2QQT_A_AINA596_1","LACTOPEROXIDASE","4ozy","POLY(BETA-D-MANNURONATE) C5 EPIMERASE","Pseudomonas syringae group genomosp. 3",4,"ARG A 186;GLU A 213;GLN A 189;PRO A 229","None;MLY A 191 ( 4.8A);None;None","1.26A","2qqtA-4ozyA:undetectable","2qqtA-4ozyA:21.72"],["2R5P_B_MK1B902_1","PROTEASE;PROTEASE","4ozy","POLY(BETA-D-MANNURONATE) C5 EPIMERASE","Pseudomonas syringae group genomosp. 3",5,"VAL A 303;ILE A 316;GLY A 315;GLY A 292;ILE A 281","None","1.03A","2r5pA-4ozyA:undetectable","2r5pA-4ozyA:13.09"],["2R5P_D_MK1D902_1","PROTEASE;PROTEASE","4ozy","POLY(BETA-D-MANNURONATE) C5 EPIMERASE","Pseudomonas syringae group genomosp. 3",5,"VAL A 303;ILE A 316;GLY A 315;GLY A 292;ILE A 281","None","1.03A","2r5pC-4ozyA:undetectable","2r5pC-4ozyA:13.09"],["2XDC_C_DVAC8_0","GRAMICIDIN A","4ozy","POLY(BETA-D-MANNURONATE) C5 EPIMERASE","Pseudomonas syringae group genomosp. 3",3,"VAL A 303;TRP A 240;TRP A 280","None","1.07A","2xdcC-4ozyA:undetectable;2xdcD-4ozyA:undetectable","2xdcC-4ozyA:5.67;2xdcD-4ozyA:5.67"],["2ZXW_W_CHDW1060_0","CYTOCHROME C OXIDASE POLYPEPTIDE 7A1;CYTOCHROME C OXIDASE SUBUNIT 1","4ozy","POLY(BETA-D-MANNURONATE) C5 EPIMERASE","Pseudomonas syringae group genomosp. 3",4,"ILE A 477;LEU A 475;ARG A 415;THR A 390","None","1.21A","2zxwN-4ozyA:undetectable;2zxwW-4ozyA:undetectable","2zxwN-4ozyA:20.85;2zxwW-4ozyA:10.75"],["2ZZN_A_SAMA401_0","UNCHARACTERIZED PROTEIN MJ0883","4ozy","POLY(BETA-D-MANNURONATE) C5 EPIMERASE","Pseudomonas syringae group genomosp. 3",5,"TYR A 291;PHE A 293;GLY A 315;VAL A 303;PHE A 301","None","1.14A","2zznA-4ozyA:undetectable","2zznA-4ozyA:22.49"],["3A8I_A_C2FA401_0","AMINOMETHYLTRANSFERASE","4ozy","POLY(BETA-D-MANNURONATE) C5 EPIMERASE","Pseudomonas syringae group genomosp. 3",5,"MET A 249;ILE A 195;VAL A 231;MET A 246;PHE A 176","None","1.43A","3a8iA-4ozyA:undetectable","3a8iA-4ozyA:21.52"],["3GCL_A_AINA609_1","LACTOPEROXIDASE","4ozy","POLY(BETA-D-MANNURONATE) C5 EPIMERASE","Pseudomonas syringae group genomosp. 3",4,"ARG A 186;GLU A 213;GLN A 189;PRO A 229","None;MLY A 191 ( 4.8A);None;None","1.23A","3gclA-4ozyA:undetectable","3gclA-4ozyA:21.72"],["3JAY_A_SAMA1102_1","STRUCTURAL PROTEIN VP3","4ozy","POLY(BETA-D-MANNURONATE) C5 EPIMERASE","Pseudomonas syringae group genomosp. 3",3,"ARG A 369;ASP A 317;ASP A 368","None","0.81A","3jayA-4ozyA:undetectable","3jayA-4ozyA:17.04"],["3JB2_A_SAMA1102_1","STRUCTURAL PROTEIN VP3","4ozy","POLY(BETA-D-MANNURONATE) C5 EPIMERASE","Pseudomonas syringae group genomosp. 3",3,"ARG A 369;ASP A 317;ASP A 368","None","0.72A","3jb2A-4ozyA:undetectable","3jb2A-4ozyA:17.04"],["3JB3_A_SAMA1102_1","STRUCTURAL PROTEIN VP3","4ozy","POLY(BETA-D-MANNURONATE) C5 EPIMERASE","Pseudomonas syringae group genomosp. 3",3,"ARG A 369;ASP A 317;ASP A 368","None","0.71A","3jb3A-4ozyA:undetectable","3jb3A-4ozyA:17.04"],["3LP1_A_NVPA701_1","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H","4ozy","POLY(BETA-D-MANNURONATE) C5 EPIMERASE","Pseudomonas syringae group genomosp. 3",5,"LEU A 467;ASN A 430;VAL A 404;GLY A 411;LEU A 475","None","1.39A","3lp1A-4ozyA:undetectable","3lp1A-4ozyA:21.54"],["3MS9_B_STIB1_2","TYROSINE-PROTEIN KINASE ABL1","4ozy","POLY(BETA-D-MANNURONATE) C5 EPIMERASE","Pseudomonas syringae group genomosp. 3",4,"TYR A 294;VAL A 376;VAL A 347;ILE A 327","None","1.18A","3ms9B-4ozyA:undetectable","3ms9B-4ozyA:20.75"],["3NRR_B_D16B520_1","DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE","4ozy","POLY(BETA-D-MANNURONATE) C5 EPIMERASE","Pseudomonas syringae group genomosp. 3",5,"HIS A 339;LEU A 391;ARG A 413;ILE A 381;LEU A 399","None","1.02A","3nrrB-4ozyA:undetectable","3nrrB-4ozyA:23.83"],["3NY4_A_SMXA309_1","BETA-LACTAMASE","4ozy","POLY(BETA-D-MANNURONATE) C5 EPIMERASE","Pseudomonas syringae group genomosp. 3",4,"ILE A 342;ARG A 413;THR A 390;GLU A 393","None","1.46A","3ny4A-4ozyA:undetectable","3ny4A-4ozyA:20.30"],["3SXJ_A_SAMA258_0","PUTATIVE METHYLTRANSFERASE","4ozy","POLY(BETA-D-MANNURONATE) C5 EPIMERASE","Pseudomonas syringae group genomosp. 3",5,"GLY A 411;GLY A 388;LEU A 432;ALA A 427;ASN A 470","None","1.29A","3sxjA-4ozyA:undetectable","3sxjA-4ozyA:19.50"],["3SXJ_B_SAMB258_0","PUTATIVE METHYLTRANSFERASE","4ozy","POLY(BETA-D-MANNURONATE) C5 EPIMERASE","Pseudomonas syringae group genomosp. 3",5,"GLY A 411;GLY A 388;LEU A 432;ALA A 427;ASN A 470","None","1.29A","3sxjB-4ozyA:undetectable","3sxjB-4ozyA:19.50"],["3ZQ8_A_DVAA8_0","VAL-GRAMICIDIN A","4ozy","POLY(BETA-D-MANNURONATE) C5 EPIMERASE","Pseudomonas syringae group genomosp. 3",3,"VAL A 303;TRP A 240;TRP A 280","None","1.11A","3zq8A-4ozyA:undetectable;3zq8B-4ozyA:undetectable","3zq8A-4ozyA:5.67;3zq8B-4ozyA:5.67"],["4EJJ_C_NCTC501_1","CYTOCHROME P450 2A6","4ozy","POLY(BETA-D-MANNURONATE) C5 EPIMERASE","Pseudomonas syringae group genomosp. 3",4,"PHE A 293;PHE A 301;ILE A 281;THR A 239","None","0.88A","4ejjC-4ozyA:undetectable","4ejjC-4ozyA:23.60"],["4FGL_C_CLQC303_0","RIBOSYLDIHYDRONICOTINAMIDE DEHYDROGENASE [QUINONE]","4ozy","POLY(BETA-D-MANNURONATE) C5 EPIMERASE","Pseudomonas syringae group genomosp. 3",4,"GLY A 114;GLY A 115;ASN A 117;GLU A 111","None","1.06A","4fglC-4ozyA:undetectable","4fglC-4ozyA:17.96"],["4M2X_A_TMQA202_2","DIHYDROFOLATE REDUCTASE","4ozy","POLY(BETA-D-MANNURONATE) C5 EPIMERASE","Pseudomonas syringae group genomosp. 3",3,"TRP A 234;GLN A 238;THR A 233","None","0.83A","4m2xA-4ozyA:undetectable","4m2xA-4ozyA:15.37"],["4Q0B_A_NVPA901_1","HIV-1 REVERSE TRANSCRIPTASE, P66 SUBUNIT","4ozy","POLY(BETA-D-MANNURONATE) C5 EPIMERASE","Pseudomonas syringae group genomosp. 3",4,"LEU A 399;VAL A 414;VAL A 435;LEU A 367","None","1.18A","4q0bA-4ozyA:undetectable","4q0bA-4ozyA:22.32"],["4Y0P_A_TE4A201_1","BETA-LACTOGLOBULIN","4ozy","POLY(BETA-D-MANNURONATE) C5 EPIMERASE","Pseudomonas syringae group genomosp. 3",5,"VAL A 231;LEU A 145;ILE A 168;ILE A 178;MET A 201","None","1.16A","4y0pA-4ozyA:undetectable","4y0pA-4ozyA:17.11"],["5ENT_C_MIYC901_1","MULTIDRUG EFFLUX PUMP SUBUNIT ACRB,MULTIDRUG EFFLUX PUMP SUBUNIT ACRB","4ozy","POLY(BETA-D-MANNURONATE) C5 EPIMERASE","Pseudomonas syringae group genomosp. 3",5,"SER A 394;GLY A 388;SER A 363;ILE A 412;ALA A 427","None","1.38A","5entC-4ozyA:undetectable","5entC-4ozyA:21.18"],["5KR2_A_ROCA101_1","PROTEASE PR5-SQV","4ozy","POLY(BETA-D-MANNURONATE) C5 EPIMERASE","Pseudomonas syringae group genomosp. 3",5,"ALA A 287;ASP A 288;ILE A 312;GLY A 292;ILE A 316","None","1.31A","5kr2A-4ozyA:undetectable","5kr2A-4ozyA:14.14"],["5M35_B_BEZB302_0","14-3-3 PROTEIN ZETA\/DELTA","4ozy","POLY(BETA-D-MANNURONATE) C5 EPIMERASE","Pseudomonas syringae group genomosp. 3",3,"MET A 103;GLN A 131;ARG A 102","None","1.14A","5m35B-4ozyA:undetectable","5m35B-4ozyA:20.37"],["5M36_A_BEZA303_0","14-3-3 PROTEIN ZETA\/DELTA","4ozy","POLY(BETA-D-MANNURONATE) C5 EPIMERASE","Pseudomonas syringae group genomosp. 3",3,"MET A 103;GLN A 131;ARG A 102","None","1.08A","5m36A-4ozyA:undetectable","5m36A-4ozyA:20.37"],["5VOO_D_C2FD3001_0","5-METHYLTETRAHYDROFOLATE HOMOCYSTEINE S-METHYLTRANSFERASE","4ozy","POLY(BETA-D-MANNURONATE) C5 EPIMERASE","Pseudomonas syringae group genomosp. 3",5,"ASN A 306;GLY A 305;MET A 246;VAL A 231;ILE A 241","None","1.15A","5vooD-4ozyA:undetectable","5vooD-4ozyA:19.81"],["6BEC_C_RBTC601_1","SCAFFOLD PROTEIN D13;SCAFFOLD PROTEIN D13;SCAFFOLD PROTEIN D13","4ozy","POLY(BETA-D-MANNURONATE) C5 EPIMERASE","Pseudomonas syringae group genomosp. 3",5,"VAL A 259;PRO A  76;PHE A 353;PRO A 318;ILE A 352","None","1.43A","6becA-4ozyA:undetectable;6becB-4ozyA:undetectable;6becC-4ozyA:undetectable","6becA-4ozyA:21.94;6becB-4ozyA:21.94;6becC-4ozyA:21.94"],["6FN9_A_BEZA302_0","14-3-3 PROTEIN ZETA\/DELTA","4ozy","POLY(BETA-D-MANNURONATE) C5 EPIMERASE","Pseudomonas syringae group genomosp. 3",3,"MET A 103;GLN A 131;ARG A 102","None","1.12A","6fn9A-4ozyA:undetectable","6fn9A-4ozyA:20.66"],["6FNA_B_BEZB302_0","14-3-3 PROTEIN ZETA\/DELTA","4ozy","POLY(BETA-D-MANNURONATE) C5 EPIMERASE","Pseudomonas syringae group genomosp. 3",3,"MET A 103;GLN A 131;ARG A 102","None","1.15A","6fnaB-4ozyA:undetectable","6fnaB-4ozyA:20.66"],["6FNB_A_BEZA301_0","14-3-3 PROTEIN ZETA\/DELTA","4ozy","POLY(BETA-D-MANNURONATE) C5 EPIMERASE","Pseudomonas syringae group genomosp. 3",3,"MET A 103;GLN A 131;ARG A 102","None","1.10A","6fnbA-4ozyA:undetectable","6fnbA-4ozyA:20.66"]]